Toxoplasmosis in Cats: Risks to Human Pregnancy and Prevention

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. The definitive host for T. gondii is the domestic cat (Felis catus) and other felids, in which the parasite undergoes sexual reproduction within the intestinal epithelium. The life cycle comprises three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts). Cats become infected through ingestion of tissue cysts from intermediate hosts (e.g., rodents, birds) or through ingestion of sporulated oocysts from the environment. Following ingestion, bradyzoites or sporozoites invade intestinal epithelial cells and undergo schizogony and gametogony, culminating in the production of unsporulated oocysts that are shed in feces. Oocyst shedding typically begins 3 to 10 days post-infection and can last for 1 to 3 weeks, during which millions of oocysts may be excreted. Unsporulated oocysts are not immediately infectious; they require 1 to 5 days of exposure to oxygen and appropriate temperature and humidity to sporulate and become infective. Sporulated oocysts are highly resilient and can remain viable in soil, water, and on surfaces for months to years.

Epidemiology and Zoonotic Significance

T. gondii is one of the most prevalent zoonotic parasites globally, infecting a wide range of warm-blooded animals, including humans. Seroprevalence in cat populations varies widely depending on geographic location, lifestyle, and age. Outdoor cats that hunt have a significantly higher risk of infection compared to strictly indoor cats. The primary route of human infection is through ingestion of sporulated oocysts from contaminated soil, water, or food, or through consumption of undercooked meat containing tissue cysts. For pregnant women, primary infection acquired during gestation poses a risk of vertical transmission to the fetus, potentially leading to congenital toxoplasmosis. The risk of fetal infection increases with gestational age, but the severity of clinical disease is greatest when infection occurs early in pregnancy. The term "cat toxoplasmosis baby" reflects the public health concern linking feline oocyst shedding to congenital infection, although direct contact with cats is not the primary transmission route; rather, inadvertent ingestion of oocysts from contaminated litter boxes, gardening soil, or unwashed produce is the principal risk.

Clinical Signs in Cats

Most immunocompetent cats infected with T. gondii remain asymptomatic. Clinical disease is more commonly observed in kittens, immunocompromised cats (e.g., those co-infected with feline immunodeficiency virus or feline leukemia virus), or cats with concurrent disease. When clinical signs occur, they are often referable to the organ systems affected by tachyzoite proliferation. Common manifestations include:

• Ocular disease: Uveitis, chorioretinitis, and anterior chamber inflammation.
• Neurological signs: Ataxia, seizures, tremors, circling, behavioral changes, and cranial nerve deficits.
• Respiratory signs: Dyspnea, tachypnea, and cough due to interstitial pneumonia.
• Gastrointestinal signs: Fever, lethargy, anorexia, diarrhea, and abdominal pain.
• Hepatic and pancreatic involvement: Jaundice, vomiting, and elevated liver enzymes.

Disseminated toxoplasmosis can involve multiple organ systems and is often fatal if untreated.

Pathology

The pathological changes associated with toxoplasmosis in cats are primarily due to the lytic effects of tachyzoite replication within host cells. In the central nervous system, focal necrosis, gliosis, and perivascular cuffing are observed. Ocular lesions include necrotizing retinitis and granulomatous uveitis. Pulmonary involvement is characterized by interstitial pneumonia with alveolar septal necrosis and infiltration of mononuclear cells. Hepatic lesions may include multifocal necrosis and hepatitis. Tissue cysts containing bradyzoites are most commonly found in the brain, skeletal muscle, and myocardium, and they persist for the life of the host without causing significant inflammation unless cyst rupture occurs.

Diagnostics

Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods.

Serology: Detection of anti-T. gondii antibodies is the most common diagnostic approach. The indirect fluorescent antibody test and enzyme-linked immunosorbent assays (ELISAs) are used to measure IgM and IgG antibodies. A positive IgM titer or a four-fold rise in IgG titer over 2 to 4 weeks suggests recent or active infection. However, serology cannot distinguish between infection and clinical disease, and many seropositive cats are asymptomatic.

Molecular diagnostics: Polymerase chain reaction (PCR) assays targeting the B1 gene or the 529 bp repetitive element of T. gondii are highly sensitive and specific. PCR can be performed on blood, aqueous humor, cerebrospinal fluid, bronchoalveolar lavage fluid, or tissue biopsies. Real-time PCR allows for quantification of parasite DNA, which may correlate with disease severity.

Fecal examination: Detection of oocysts in feces is possible during the acute shedding period, but oocysts are morphologically indistinguishable from those of Hammondia hammondi and Besnoitia species. Molecular confirmation is required for definitive identification. Fecal flotation using Sheather's sugar solution or zinc sulfate centrifugation is the standard method for oocyst concentration.

Histopathology and immunohistochemistry: Tissue biopsy or necropsy specimens can be stained with hematoxylin and eosin to identify tachyzoites and tissue cysts. Immunohistochemical staining using anti-T. gondii antibodies provides definitive confirmation of the parasite in tissue sections.

Imaging: Thoracic radiography may reveal a diffuse interstitial or alveolar pattern in cats with pneumonia. Ocular ultrasonography can assist in characterizing intraocular lesions.

Treatment

Treatment is indicated for cats with clinical toxoplasmosis. The standard therapeutic regimen consists of clindamycin administered at 10 to 12 mg/kg orally or intramuscularly every 12 hours for 2 to 4 weeks. Alternative therapies include trimethoprim-sulfonamide combinations (15 mg/kg every 12 hours) or pyrimethamine (0.25 to 0.5 mg/kg every 24 hours) in combination with a sulfonamide. Supportive care, including fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids for ocular or neurological inflammation, may be necessary. Treatment does not eliminate tissue cysts, and cats remain latently infected for life.

Prevention and Control

Prevention of toxoplasmosis in cats and reduction of zoonotic risk to pregnant women require a multifaceted approach.

Management of cats:

• Feed cats only commercially processed, cooked, or canned food to prevent ingestion of tissue cysts.
• Prevent hunting behavior by keeping cats indoors.
• Cover sandboxes and garden areas to discourage feline defecation.
• Clean litter boxes daily, as oocysts require 1 to 5 days to sporulate and become infective. Litter box cleaning should be performed by a non-pregnant individual wearing gloves, followed by hand hygiene.
• Dispose of cat feces in sealed bags.

Environmental hygiene:

• Wear gloves when gardening or handling soil that may be contaminated with cat feces.
• Wash hands thoroughly after contact with soil, sand, or raw meat.
• Wash all fruits and vegetables before consumption.
• Cook meat to an internal temperature sufficient to kill tissue cysts (at least 67 degrees Celsius).

Public health education: Pregnant women and immunocompromised individuals should be counseled about the risks of zoonotic transmission. The risk of acquiring toxoplasmosis from a pet cat is low if basic hygiene measures are followed. Routine serological screening of cats is not recommended for public health purposes, as a positive antibody titer indicates past exposure and immunity, not active shedding. Only cats that are actively shedding oocysts pose a direct risk, and shedding is typically transient and occurs only after primary infection.

The following decision tree summarizes the recommended approach for managing feline toxoplasmosis risk in households with pregnant women.

flowchart TD
    A[Pregnant woman in household with cat], > B{Is the cat strictly indoor?}
    B, >|Yes| C[Low risk. Maintain indoor lifestyle. Feed cooked food. Clean litter box daily.]
    B, >|No| D[Outdoor access increases risk. Restrict to indoors if possible.]
    C, > E[Non-pregnant person cleans litter box. Wear gloves. Wash hands.]
    D, > E
    E, > F[Monitor cat for clinical signs: fever, lethargy, neurological signs.]
    F, > G{Clinical signs present?}
    G, >|Yes| H[Veterinary consultation. Serology and PCR testing. Consider treatment.]
    G, >|No| I[No further action. Routine hygiene continues.]
    H, > J[If active infection confirmed, isolate cat from pregnant woman during shedding period.]
    J, > K[Repeat hygiene measures. Environmental decontamination with 10% ammonia or boiling water.]

Conclusion

Toxoplasmosis in cats is a significant zoonotic concern, particularly for pregnant women and immunocompromised individuals. Understanding the life cycle of T. gondii, the epidemiology of feline infection, and the principles of prevention is essential for veterinary professionals advising clients. While the risk of congenital transmission from a household cat is low when appropriate hygiene measures are implemented, education and proactive management remain the cornerstones of prevention. Veterinary practitioners play a critical role in communicating evidence-based strategies to mitigate the risks associated with feline toxoplasmosis.

References

1. Dubey, J.P. Toxoplasmosis of Animals and Humans. CRC Press.
2. Dubey, J.P., and Beattie, C.P. Toxoplasmosis of Animals and Man. CRC Press.
3. Lappin, M.R. Feline toxoplasmosis. In: Greene, C.E., editor. Infectious Diseases of the Dog and Cat. Elsevier.
4. Montoya, J.G., and Liesenfeld, O. Toxoplasmosis. The Lancet.
5. Tenter, A.M., Heckeroth, A.R., and Weiss, L.M. Toxoplasma gondii: from animals to humans. International Journal for Parasitology.
6. Elmore, S.A., et al. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends in Parasitology.
7. Dubey, J.P., and Jones, J.L. Toxoplasma gondii infection in humans and animals in the United States. International Journal for Parasitology.
8. Hill, D., and Dubey, J.P. Toxoplasma gondii: transmission, diagnosis, and prevention. Clinical Microbiology and Infection.
9. Robert-Gangneux, F., and Darde, M.L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical Microbiology Reviews.
10. Weiss, L.M., and Dubey, J.P. Toxoplasmosis: A history of clinical observations. International Journal for Parasitology.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.